CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade $ TalkMed - 5G3sg CFD

0.382
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.021
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0264 %
Charges from borrowed part ($-1.06)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0264%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0264 %
Charges from borrowed part ($-1.06)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0181%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency SGD
Margin 20%
Stock exchange Singapore
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.382
Open* 0.382
1-Year Change* -6.14%
Day's Range* 0.382 - 0.382
52 wk Range 0.38-0.425
Average Volume (10 days) N/A
Average Volume (3 months) 0.139
Market Cap 529.022
P/E Ratio 20.0904
Shares Outstanding 1322550000
Revenue 64.361
EPS 0.01991
Dividend (Yield %) 6
Beta 0.2479
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 7, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Dec 6, 2022 0.382 -0.010 -2.55% 0.392 0.392 0.382
Dec 5, 2022 0.392 0.000 0.00% 0.392 0.397 0.392
Dec 2, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 30, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
Nov 29, 2022 0.377 0.000 0.00% 0.377 0.377 0.377
Nov 28, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Nov 23, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Nov 22, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Nov 18, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Nov 17, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Nov 11, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Nov 9, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Nov 3, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Nov 2, 2022 0.392 0.005 1.29% 0.387 0.397 0.387
Nov 1, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Oct 31, 2022 0.387 0.000 0.00% 0.387 0.387 0.387
Oct 28, 2022 0.377 -0.015 -3.83% 0.392 0.392 0.377
Oct 27, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
Oct 26, 2022 0.397 0.000 0.00% 0.397 0.397 0.397

$ TalkMed Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 68.913 61.361 61.278 75.919 62.136 60.746
Revenue 68.913 61.361 61.278 75.919 62.136 60.746
Total Operating Expense 23.425 22.823 26.138 33.52 36.244 32.385
Selling/General/Admin. Expenses, Total 18.365 18.337 22.909 25.402 26.536 26.604
Interest Expense (Income) - Net Operating 2.899 1.065 -0.982 -1.185 -0.472 -0.114
Other Operating Expenses, Total 2.161 3.421 4.211 5.878 4.766 4.718
Operating Income 45.488 38.538 35.14 42.399 25.892 28.361
Net Income Before Taxes 45.488 38.538 34.003 41.349 24.807 27.286
Net Income After Taxes 36.881 31.197 27.214 32.806 18.517 21.428
Minority Interest 0.51 0.839 1.694 2.945 4.252 3.687
Net Income Before Extra. Items 37.391 32.036 28.908 35.751 22.769 25.115
Net Income 37.391 32.036 28.908 35.751 22.769 25.115
Income Available to Common Excl. Extra. Items 37.391 32.036 28.908 35.751 22.769 25.115
Income Available to Common Incl. Extra. Items 37.391 32.036 28.908 35.751 22.769 25.115
Diluted Net Income 37.391 32.036 28.908 35.751 22.769 25.115
Diluted Weighted Average Shares 1314.29 1314.62 1314.8 1314.72 1324.25 1326.99
Diluted EPS Excluding Extraordinary Items 0.02845 0.02437 0.02199 0.02719 0.01719 0.01893
Dividends per Share - Common Stock Primary Issue 0.02282 0.02131 0.01826 0.023 0.0135 0.016
Diluted Normalized EPS 0.02845 0.02437 0.02199 0.02719 0.01827 0.01815
Interest Income (Expense), Net Non-Operating -1.137 -1.05 -1.085 -1.075
Depreciation / Amortization 3.425 3.513 2.488
Unusual Expense (Income) 1.901 -1.311
Q2 2020 Q3 2020 Q4 2020 Q2 2021 Q4 2021
Total revenue 30.675 14.118 31.461 28.854 31.892
Revenue 30.675 14.118 31.461 28.854 31.892
Total Operating Expense 17.828 8.019 18.416 15.971 16.414
Selling/General/Admin. Expenses, Total 14.707 6.615 11.829 12.617 13.987
Depreciation / Amortization 1.689 0.951 1.824 1.199 1.289
Interest Expense (Income) - Net Operating -0.281 0.042 0.095 -0.019 -0.095
Other Operating Expenses, Total 1.713 0.411 1.261 2.174 1.233
Operating Income 12.847 6.099 13.045 12.883 15.478
Interest Income (Expense), Net Non-Operating -0.953 -0.164 -0.132 -0.356 -0.719
Net Income Before Taxes 11.894 5.935 12.913 12.527 14.759
Net Income After Taxes 9.005 4.62 9.512 9.734 11.694
Minority Interest 1.69 0.557 2.562 1.076 2.611
Net Income Before Extra. Items 10.695 5.177 12.074 10.81 14.305
Net Income 10.695 5.177 12.074 10.81 14.305
Income Available to Common Excl. Extra. Items 10.695 5.177 12.074 10.81 14.305
Income Available to Common Incl. Extra. Items 10.695 5.177 12.074 10.81 14.305
Diluted Net Income 10.695 5.177 12.074 10.81 14.305
Diluted Weighted Average Shares 1321.93 1326.68 1326.58 1326.52 1327.46
Diluted EPS Excluding Extraordinary Items 0.00809 0.0039 0.0091 0.00815 0.01078
Dividends per Share - Common Stock Primary Issue 0 0.006 0.0135 0.007 0.009
Diluted Normalized EPS 0.00809 0.0039 0.01099 0.00815 0.01078
Unusual Expense (Income) 3.407 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 70.928 80.132 83.637 94.431 91.313 92.424
Cash and Short Term Investments 63.996 71.051 73.993 80.698 79.43 82.164
Cash 11.285 9.628 13.421 18.373 10.132 15.258
Short Term Investments 52.711 61.423 60.572 62.325 69.298 66.906
Total Receivables, Net 6.691 8.641 8.714 12.267 10.295 9.002
Accounts Receivable - Trade, Net 6.425 8.372 8.307 11.422 9.503 8.365
Total Inventory 0.063 0.167 0.282 0.856 1.004 0.772
Prepaid Expenses 0.178 0.273 0.648 0.61 0.584 0.486
Total Assets 76.457 85.356 91.272 106.075 104.62 108.785
Property/Plant/Equipment, Total - Net 0.511 0.674 4.227 8.739 6.172 8.514
Property/Plant/Equipment, Total - Gross 1.027 1.556 5.485 11.461 13.724 15.135
Accumulated Depreciation, Total -0.516 -0.882 -1.258 -2.722 -7.552 -6.621
Long Term Investments 5.004 4.541 3.404 2.887 7.11 7.437
Note Receivable - Long Term 0.014 0.41
Total Current Liabilities 12.324 11.503 12.735 16.768 17.411 14.245
Accounts Payable 1.735 0.295 0.522 1.284 0.402 0.628
Accrued Expenses 2.018 2.56 3.935 3.353 4.152 3.397
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 8.571 8.648 8.278 10.357 11.071 8.245
Total Liabilities 12.88 13.027 17.506 22.97 21.186 18.607
Total Long Term Debt 0 0 0 2.119 2.69 4.493
Minority Interest 0.528 0.181 -0.415 -1.414 -4.679 -2.678
Other Liabilities, Total 0.028 1.343 5.186 5.497 5.764 2.547
Total Equity 63.577 72.329 73.766 83.105 83.434 90.178
Common Stock 22.273 22.273 22.273 22.438 23.905 24.505
Retained Earnings (Accumulated Deficit) 41.304 50.688 51.988 60.957 59.316 65.109
Total Liabilities & Shareholders’ Equity 76.457 85.356 91.272 106.075 104.62 108.785
Total Common Shares Outstanding 1314.29 1314.29 1314.29 1314.5 1318.05 1320.11
Other Long Term Assets, Total 0.009 0.004 0.018 0.025 0
Other Equity, Total -0.632 -0.495 -0.29 0.213 0.564
Current Port. of LT Debt/Capital Leases 1.774 1.786 1.975
Capital Lease Obligations 2.119 2.69 4.493
Jun 2020 Sep 2020 Dec 2020 Jun 2021 Dec 2021
Total Current Assets 92.641 99.943 91.313 89.516 92.424
Cash and Short Term Investments 80.914 90.795 79.43 80.945 82.164
Cash & Equivalents 80.914 90.795 79.43 80.945 82.164
Total Receivables, Net 9.878 7.312 10.295 7.064 9.002
Accounts Receivable - Trade, Net 9.878 7.312 10.295 7.064 9.002
Total Inventory 0.964 0.963 1.004 1.047 0.772
Prepaid Expenses 0.885 0.873 0.584 0.46 0.486
Total Assets 102.265 111.72 104.62 101.839 108.785
Property/Plant/Equipment, Total - Net 7.862 9.517 6.172 5.394 8.514
Long Term Investments 1.741 2.226 7.11 6.892 7.437
Other Long Term Assets, Total 0.021 0.034 0.025 0.037 0
Total Current Liabilities 19.757 18.32 17.411 13.015 14.245
Accounts Payable 3.677 1.782 1.982 2.204 2.17
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.925 1.945 1.786 1.161 1.975
Other Current Liabilities, Total 14.155 14.593 13.643 9.65 10.1
Total Liabilities 23.975 27.554 21.186 17.044 18.607
Total Long Term Debt 1.635 2.97 2.69 2.244 4.493
Capital Lease Obligations 1.635 2.97 2.69 2.244 4.493
Minority Interest -3.065 0.515 -4.679 -0.829 -2.678
Other Liabilities, Total 5.648 5.749 5.764 2.614 2.547
Total Equity 78.29 84.166 83.434 84.795 90.178
Common Stock 23.905 23.905 23.905 24.505 24.505
Retained Earnings (Accumulated Deficit) 54.499 60.102 59.316 59.865 65.109
Other Equity, Total -0.114 0.159 0.213 0.425 0.564
Total Liabilities & Shareholders’ Equity 102.265 111.72 104.62 101.839 108.785
Total Common Shares Outstanding 1318.05 1318.05 1318.05 1320.11 1320.11
Note Receivable - Long Term 0.41
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 45.488 38.538 34.003 41.349 24.807 27.286
Cash From Operating Activities 44.818 30.988 30.079 35.883 31.273 23.158
Cash From Operating Activities 0.266 0.366 0.376 3.425 3.513 2.488
Non-Cash Items 2.899 1.582 0.819 0.272 6.316 0.776
Cash Taxes Paid 8.339 8.586 7.34 6.77 5.713 9.101
Changes in Working Capital -3.835 -9.498 -5.119 -9.163 -3.363 -7.392
Cash From Investing Activities -0.254 -0.529 -3.929 -2.003 -8.446 -1.977
Capital Expenditures -0.254 -0.529 -3.929 -2.128 -1.954 -0.77
Other Investing Cash Flow Items, Total 0 0.125 -6.492 -1.207
Cash From Financing Activities -30.13 -23.404 -23.208 -27.175 -24.095 -18.447
Financing Cash Flow Items 0 1.6 4.8 1.883 2.51 2.8
Total Cash Dividends Paid -30.13 -25.004 -28.008 -27.142 -25.042 -19.141
Net Change in Cash 14.434 7.055 2.942 6.705 -1.268 2.734
Cash Interest Paid 0.122 0.237 0.219
Issuance (Retirement) of Debt, Net -1.916 -1.563 -2.106
Jun 2020 Sep 2020 Dec 2020 Jun 2021 Dec 2021
Net income/Starting Line 11.894 17.829 24.807 12.527 27.286
Cash From Operating Activities 18.495 25.867 31.273 11.307 23.158
Cash From Operating Activities 1.689 2.64 3.513 1.199 2.488
Non-Cash Items 2.528 3.161 6.316 0.802 0.776
Cash Taxes Paid 1.429 3.556 5.713 5.962 9.101
Cash Interest Paid 0.071 0.182 0.237 0.119 0.219
Changes in Working Capital 2.384 2.237 -3.363 -3.221 -7.392
Cash From Investing Activities -0.199 -1.037 -8.446 -0.398 -1.977
Capital Expenditures -0.199 -1.037 -1.954 -0.398 -0.77
Other Investing Cash Flow Items, Total 0 0 -6.492 -1.207
Cash From Financing Activities -18.08 -14.733 -24.095 -9.394 -18.447
Total Cash Dividends Paid -17.134 -17.134 -25.042 -9.9 -19.141
Issuance (Retirement) of Debt, Net -0.946 -1.359 -1.563 -1.094 -2.106
Net Change in Cash 0.216 10.097 -1.268 1.515 2.734
Financing Cash Flow Items 3.76 2.51 1.6 2.8
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Ladyhill Holdings Pte. Ltd. Corporation 64.9434 858912000 0 2022-03-15 LOW
Khoo (Kei Siong) Individual Investor 7.5127 99360000 0 2022-03-15 LOW
Teo (Cheng Peng) Individual Investor 7.4293 98256000 0 2022-03-15 LOW
Lim (Hong Liang) Individual Investor 3.5894 47472000 30000000 2022-03-15 LOW
See (Hui Ti) Individual Investor 0.461 6096623 20224 2022-03-15 LOW
Lim (Bee Kok) Individual Investor 0.3686 4875000 198000 2022-03-15 LOW
Foo (Kian Fong) Individual Investor 0.2128 2813890 -218076 2022-03-15 LOW
Lai (Jason Justin) Individual Investor 0.1527 2020000 0 2022-03-15 LOW
Thng (Yongxian) Individual Investor 0.1271 1681100 0 2022-03-15 LOW
Chan (Jin Hoe) Individual Investor 0.121 1600000 0 2022-03-15 LOW
Ng (Lin Chieh Kelvin) Individual Investor 0.1134 1500000 0 2022-03-15 LOW
Tan (Fan Hao Matthew) Individual Investor 0.1134 1500000 0 2022-03-15 LOW
Tan (Yii Hsien Barnabas) Individual Investor 0.1134 1500000 0 2022-03-15 LOW
Sng (Su Ying Marian) Individual Investor 0.1051 1390000 0 2022-03-15 LOW
Zee (Ying Kiat) Individual Investor 0.0896 1185339 1185339 2022-03-15
Chandra Das S O Rajagopal Sitaram Individual Investor 0.0832 1100300 101300 2022-03-28
Kok (Jaan Yang) Individual Investor 0.0817 1080139 90078 2022-03-15 LOW
Cheng (Tim Jeng) Individual Investor 0.0815 1078000 0 2022-03-15 LOW
Leong (Ching Ching) Individual Investor 0.0227 300000 0 2022-01-21 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

TalkMed Company profile

About TalkMed Group Ltd

TalkMed Group Limited is a Singapore-based investment holding company. The Company’s Oncology services segment is engaged in the provision of oncology services to Parkway Cancer Centre, a division of Parkway Hospitals Singapore Pte. Ltd., Thu Cuc International General Hospital in Hanoi, Vietnam and Hong Kong Integrated Oncology Centre Holdings Limited. The Company has expanded its oncology services to China. Its Stem cell related products and services segment is engaged in the provision of services related to processing, culturing and storage of stem cells through its subsidiary, Stem Med Pte. Ltd. (Stem Med) to Parkway Cancer Centre, a division of Parkway Hospitals Singapore Pte. Ltd., StemCord Pte Ltd, the non-controlling shareholder of Stem Med and other individual customers. The Cellular and gene therapy related products and services segment is engaged in the provision of goods and services related to cellular and gene therapy through its subsidiary, CellVec Pte. Ltd.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, TalkMed Group Ltd revenues decreased 2% to SP$60.7M. Net income increased 10% to SP$25.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Impairment loss decrease from SP$3.4M (expense) to SP$0K, Cost of share-based payments to employee decrease of 76% to SP$512K (expense).

Industry: Healthcare Facilities & Services (NEC)

101 Thomson Road
#09-02 United Square
307591
SG

Income Statement

People also watch

Oil - Crude

72.78 Price
+0.460% 1D Chg, %
Long position overnight fee -0.0157%
Short position overnight fee 0.0013%
Overnight fee time 22:00 (UTC)
Spread 0.03

US100

11,521.30 Price
+0.400% 1D Chg, %
Long position overnight fee -0.0164%
Short position overnight fee 0.0059%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

16,863.65 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Natural Gas

5.76 Price
-0.710% 1D Chg, %
Long position overnight fee 0.0438%
Short position overnight fee -0.0682%
Overnight fee time 22:00 (UTC)
Spread 0.005

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading